Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Finasteride improves hidradenitis suppurativa in children with no adverse effects.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Researchers found that dissecting folliculitis of the scalp is linked to obesity, severity increases with duration and number of nodules, and early treatment is important to prevent scarring.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

A rare fungal infection on a child's scalp was successfully treated with antifungal medication.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

DCPA is a chronic leg infection often related to Staphylococcus aureus, affecting mostly young men in India.

An 84-year-old man got a rare scalp condition from using imiquimod cream, which was cured with systemic steroids.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Itraconazole may cause low platelet and white blood cell counts.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Isotretinoin was not effective in treating facial lichen planopilaris.

Older patients with Cushing's syndrome often have different symptoms and treatment outcomes compared to younger patients.